Antifungal Drugs Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Antifungal Drugs Market to 2027 - Global Analysis and Forecasts By Drug Type(Azoles, Echinocandins, Allylamines, Polyenes and others.); Therapeutic Indication(Dematophytosis, Candidiasis and other Therapeutic indications.)

Report Code: TIPRE00003745 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Antifungal Drugs are used for treating common fungal infections such as fungal nail infection, vaginal infection and others that appear on the external surface of the body and other fungal invasive infection that occur inside the tissue of the body or in an internal organ such as lungs and brains. It works against the fungal infection by either killing the fungal cells or by constraining their growth.

MARKET DYNAMICS
The Antifungal Drugs market is anticipated to grow in the forecast period owing to driving factors such as increasing incidence of fungal infection, rising awareness levels pertaining to myriad fungal infections and favorable government funds to shoot out the antifungal diseases. Nevertheless, side effects of the drugs such as allergies and expensiveness of the drugs could impact the growth of the market during the forecast period.

MARKET SCOPE
The "Global Antifungal Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Antifungal Drugs market with detailed market segmentation by Drug type, Therapeutic Indication and geography. The global Antifungal Drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Antifungal Drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Antifungal Drugs market is segmented on the basis of Drug Type and Therapeutic indication. On the basis of Drug type the market is segmented as Azoles, Echinocandins, Allylamines, Polyenes and others. On the basis of Therapeutic indication the market is segmented as Dematophytosis, Candidiasis and other Therapeutic indications.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Antifungal Drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Antifungal Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Antifungal Drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Antifungal Drugs market in these regions.

MARKET PLAYERS
The reports cover key developments in the Antifungal Drugs Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Antifungal Drugs Market are anticipated to lucrative growth opportunities in the future with the rising demand for Antifungal Drugs in the global market. Below mentioned is the list of few companies engaged in the Antifungal Drugs market.

The report also includes the profiles of key Antifungal Drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Merck & Co
  • Novartis AG
  • Sanofi
  • Pfizer, Inc
  • Bayer AG
  • Enzon Pharmaceuticals, Inc.
  • GlaxoSmithKline plc
  • Abbott
  • Sigma-Aldrich
  • Glenmark
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antifungal Drugs Market - By Drug Type
1.3.2 Antifungal Drugs Market - By Therapeutic Indication
1.3.3 Antifungal Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ANTIFUNGAL DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIFUNGAL DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIFUNGAL DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIFUNGAL DRUGS - GLOBAL MARKET OVERVIEW
6.2. ANTIFUNGAL DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIFUNGAL DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. AZOLES
7.3.1. Overview
7.3.2. Azoles Market Forecast and Analysis
7.4. ECHINOCANDINS
7.4.1. Overview
7.4.2. Echinocandins Market Forecast and Analysis
7.5. ALLYLAMINES
7.5.1. Overview
7.5.2. Allylamines Market Forecast and Analysis
7.6. POLYENES AND OTHERS
7.6.1. Overview
7.6.2. Polyenes and others Market Forecast and Analysis
8. ANTIFUNGAL DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - THERAPEUTIC INDICATION
8.1. OVERVIEW
8.2. THERAPEUTIC INDICATION MARKET FORECASTS AND ANALYSIS
8.3. DEMATOPHYTOSIS
8.3.1. Overview
8.3.2. Dematophytosis Market Forecast and Analysis
8.4. CANDIDIASIS AND OTHER THERAPEUTIC INDICATIONS
8.4.1. Overview
8.4.2. Candidiasis and other Therapeutic indications Market Forecast and Analysis
9. ANTIFUNGAL DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Antifungal Drugs Market Overview
9.1.2 North America Antifungal Drugs Market Forecasts and Analysis
9.1.3 North America Antifungal Drugs Market Forecasts and Analysis - By Drug Type
9.1.4 North America Antifungal Drugs Market Forecasts and Analysis - By Therapeutic Indication
9.1.5 North America Antifungal Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Antifungal Drugs Market
9.1.5.1.1 United States Antifungal Drugs Market by Drug Type
9.1.5.1.2 United States Antifungal Drugs Market by Therapeutic Indication
9.1.5.2 Canada Antifungal Drugs Market
9.1.5.2.1 Canada Antifungal Drugs Market by Drug Type
9.1.5.2.2 Canada Antifungal Drugs Market by Therapeutic Indication
9.1.5.3 Mexico Antifungal Drugs Market
9.1.5.3.1 Mexico Antifungal Drugs Market by Drug Type
9.1.5.3.2 Mexico Antifungal Drugs Market by Therapeutic Indication
9.1.5.4 US Antifungal Drugs Market
9.1.5.4.1 US Antifungal Drugs Market by Drug Type
9.1.5.4.2 US Antifungal Drugs Market by Therapeutic Indication
9.2. EUROPE
9.2.1 Europe Antifungal Drugs Market Overview
9.2.2 Europe Antifungal Drugs Market Forecasts and Analysis
9.2.3 Europe Antifungal Drugs Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Antifungal Drugs Market Forecasts and Analysis - By Therapeutic Indication
9.2.5 Europe Antifungal Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Antifungal Drugs Market
9.2.5.1.1 Germany Antifungal Drugs Market by Drug Type
9.2.5.1.2 Germany Antifungal Drugs Market by Therapeutic Indication
9.2.5.2 France Antifungal Drugs Market
9.2.5.2.1 France Antifungal Drugs Market by Drug Type
9.2.5.2.2 France Antifungal Drugs Market by Therapeutic Indication
9.2.5.3 Italy Antifungal Drugs Market
9.2.5.3.1 Italy Antifungal Drugs Market by Drug Type
9.2.5.3.2 Italy Antifungal Drugs Market by Therapeutic Indication
9.2.5.4 Spain Antifungal Drugs Market
9.2.5.4.1 Spain Antifungal Drugs Market by Drug Type
9.2.5.4.2 Spain Antifungal Drugs Market by Therapeutic Indication
9.2.5.5 United Kingdom Antifungal Drugs Market
9.2.5.5.1 United Kingdom Antifungal Drugs Market by Drug Type
9.2.5.5.2 United Kingdom Antifungal Drugs Market by Therapeutic Indication
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Antifungal Drugs Market Overview
9.3.2 Asia-Pacific Antifungal Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Antifungal Drugs Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Antifungal Drugs Market Forecasts and Analysis - By Therapeutic Indication
9.3.5 Asia-Pacific Antifungal Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Antifungal Drugs Market
9.3.5.1.1 Australia Antifungal Drugs Market by Drug Type
9.3.5.1.2 Australia Antifungal Drugs Market by Therapeutic Indication
9.3.5.2 China Antifungal Drugs Market
9.3.5.2.1 China Antifungal Drugs Market by Drug Type
9.3.5.2.2 China Antifungal Drugs Market by Therapeutic Indication
9.3.5.3 India Antifungal Drugs Market
9.3.5.3.1 India Antifungal Drugs Market by Drug Type
9.3.5.3.2 India Antifungal Drugs Market by Therapeutic Indication
9.3.5.4 Japan Antifungal Drugs Market
9.3.5.4.1 Japan Antifungal Drugs Market by Drug Type
9.3.5.4.2 Japan Antifungal Drugs Market by Therapeutic Indication
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Antifungal Drugs Market Overview
9.4.2 Middle East and Africa Antifungal Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Antifungal Drugs Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Antifungal Drugs Market Forecasts and Analysis - By Therapeutic Indication
9.4.5 Middle East and Africa Antifungal Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Antifungal Drugs Market
9.4.5.1.1 South Africa Antifungal Drugs Market by Drug Type
9.4.5.1.2 South Africa Antifungal Drugs Market by Therapeutic Indication
9.4.5.2 Saudi Arabia Antifungal Drugs Market
9.4.5.2.1 Saudi Arabia Antifungal Drugs Market by Drug Type
9.4.5.2.2 Saudi Arabia Antifungal Drugs Market by Therapeutic Indication
9.4.5.3 U.A.E Antifungal Drugs Market
9.4.5.3.1 U.A.E Antifungal Drugs Market by Drug Type
9.4.5.3.2 U.A.E Antifungal Drugs Market by Therapeutic Indication
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Antifungal Drugs Market Overview
9.5.2 South and Central America Antifungal Drugs Market Forecasts and Analysis
9.5.3 South and Central America Antifungal Drugs Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Antifungal Drugs Market Forecasts and Analysis - By Therapeutic Indication
9.5.5 South and Central America Antifungal Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Antifungal Drugs Market
9.5.5.1.1 Brazil Antifungal Drugs Market by Drug Type
9.5.5.1.2 Brazil Antifungal Drugs Market by Therapeutic Indication
9.5.5.2 Argentina Antifungal Drugs Market
9.5.5.2.1 Argentina Antifungal Drugs Market by Drug Type
9.5.5.2.2 Argentina Antifungal Drugs Market by Therapeutic Indication
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ANTIFUNGAL DRUGS MARKET, KEY COMPANY PROFILES
11.1. MERCK & CO
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. NOVARTIS AG
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. SANOFI-AVENTIS
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. PFIZER, INC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BAYER AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ENZON PHARMACEUTICALS, INC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. GLAXOSMITHKLINE PLC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ABBOTT
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SIGMA-ALDRICH CO.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. GLENMARK
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Merck & Co
2. Novartis AG
3. Sanofi
4. Pfizer, Inc
5. Bayer AG
6. Enzon Pharmaceuticals, Inc.
7. GlaxoSmithKline plc
8. Abbott
9. Sigma-Aldrich
10. Glenmark